Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted therapy for social anxiety in autistic adults
NCT02008396Phase 2Completed
- Sponsor
- Lykos Therapeutics
- Start
- Apr 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in Social Anxiety Disorder (SAD), sponsored by Lykos Therapeutics. Started Apr 2014; status: completed.
02
Drugs
midomafetamine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02008396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008396.